EXTEND Exercise Trial
NCT02256111
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
26
Enrollment
OTHER
Sponsor class
Conditions
Non-metastatic, Hormone naïve Prostate Cancer
Interventions
DRUG:
Enzalutamide
DRUG:
Androgen deprivation therapy
BEHAVIORAL:
Supervised exercise training
Sponsor
Duke University